KRTL BioTech

Citadel's Ken Griffin defends controversial Wall Street practice, says firm would adapt if it were outlawed

Citadel's Ken Griffin defends controversial Wall Street practice, says firm would adapt if it were outlawed

While new information was limited, some clarity on Robinhood's restriction of trades and Citadel's role in payment for order flow came to the surface.